TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12368674

Group type: EXPERIMENTAL
Intervention: VR training (MIST VR simulator diathermy task)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non‐VR training
Number of subjects: 16
Study: 9672727

Group type: EXPERIMENTAL
Intervention: Modified Cognitive-Behavioural Therapy (MCBT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conjoint Family Therapy (FT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Eclectic Therapy (ET)
Number of subjects: 32
Study: 8026119

Group type: EXPERIMENTAL
Intervention: AN‐69 dialyzer
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Polysulfone dialyzer
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ACE inhibitor
Number of subjects: 12

Group type: COMPARATOR
Intervention: No ACE inhibitor
Number of subjects: 12
Study: 2684661

Group type: EXPERIMENTAL
Intervention: Etomidate in propylene glycol (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Etomidate in ethanol (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 1037229

Group type: EXPERIMENTAL
Intervention: Ethyl apovincaminate (Cavinton)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Xantinol nicotinate
Number of subjects: 143
Study: 30866128

Group type: EXPERIMENTAL
Intervention: Persian translation of work ability index (WAI) questionnaire
Number of subjects: 750
Study: 27825957

Group type: EXPERIMENTAL
Intervention: 300 ml water
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 25 ml water
Number of subjects: 156

Group type: COMPARATOR
Intervention: No water
Number of subjects: 156
Study: 26605084

Group type: EXPERIMENTAL
Intervention: Symptom monitoring and peak flow training with feedback
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Peak flow training without feedback
Number of subjects: 227

Group type: COMPARATOR
Intervention: No peak flow training
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Signal detection training with feedback
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Signal detection training without feedback
Number of subjects: 227

Group type: COMPARATOR
Intervention: No training
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Overall symptom perception interventions
Number of subjects: 227
Study: 23564595

Group type: EXPERIMENTAL
Intervention: 74 g Corinthian raisins
Number of subjects: 30

Group type: COMPARATOR
Intervention: 50 g glucose (reference food)
Number of subjects: 30
Study: 21775755

Group type: EXPERIMENTAL
Intervention: α-lipoic acid (ALA) 600 mg once daily
Number of subjects: 460

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 460
Study: 19857148

Group type: EXPERIMENTAL
Intervention: Fluconazole for primary prophylaxis in autologous HSCT recipients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluconazole for primary prophylaxis in low-risk allogeneic HSCT recipients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mould-active agent for high-risk allogeneic HSCT recipients
Number of subjects: 0
Study: 17030231

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 microg) with fluticasone propionate (100 microg) administered twice daily for 12 weeks
Number of subjects: 183

Group type: COMPARATOR
Intervention: Montelukast administered daily for 12 weeks
Number of subjects: 183
Study: 12614193

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/day
Number of subjects: 946

Group type: COMPARATOR
Intervention: Captopril 50 mg t.i.d.
Number of subjects: 946

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 946

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 946
Study: 10828632

Group type: EXPERIMENTAL
Intervention: Petrolatum-based formulation delivered via a novel diaper
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diaper (identical to test product without petrolatum formulation)
Number of subjects: 0
Study: 9124167

Group type: EXPERIMENTAL
Intervention: Exercise training (interval bicycle ergometer and treadmill walking training exercises)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Activity restriction
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 18
Study: 8400729

Group type: EXPERIMENTAL
Intervention: Chemical zona pellucida thinning (experimental group, n = 110)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (unmanipulated embryos, n = 108)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Chemical zona thinning applied to embryos with less than 4.0 microns variation in zona thickness
Number of subjects: 218
Study: 2876485

Group type: EXPERIMENTAL
Intervention: Clonazepam (1 mg h.s.)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Temazepam (30 mg h.s.)
Number of subjects: 10
Study: 31828166

Group type: EXPERIMENTAL
Intervention: Adjusted insulin (daily insulin needed on the day after hemodialysis)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Nonadjusted insulin (25% decrease in daily insulin needed on the day after hemodialysis)
Number of subjects: 51
Study: 30591697

Group type: EXPERIMENTAL
Intervention: Weight loss (10% reduction over six months) in group II (decreased AIP)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Weight loss (10% reduction over six months) in group I (increased AIP)
Number of subjects: 52
Study: 26437376

Group type: EXPERIMENTAL
Intervention: ITX5061 (150 mg immediately before and after transplant and daily for 1 week)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (first 13 patients did not receive drug)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: ITX5061
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control
Number of subjects: 23
Study: 25142566

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mindfulness-based therapy for insomnia (MBTI)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Self-monitoring (SM)
Number of subjects: 54
Study: 22052061

Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis
Number of subjects: 0
Study: 19488642

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Combination hydralazine/nitrate
Number of subjects: 3
Study: 17250745

Group type: EXPERIMENTAL
Intervention: 2 mg of physostigmine
Number of subjects: 100

Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 100
Study: 15774291

Group type: EXPERIMENTAL
Intervention: Glutamine granules (0.5 g/kg per day for 14 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (glycine)
Number of subjects: 48
Study: 12081987

Group type: EXPERIMENTAL
Intervention: Omapatrilat 80 mg daily
Number of subjects: 167

Group type: COMPARATOR
Intervention: Enalapril 40 mg daily
Number of subjects: 167
Study: 9810809

Group type: EXPERIMENTAL
Intervention: Chromium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7656295

Group type: EXPERIMENTAL
Intervention: Water rinsing after brushing
Number of subjects: 4294

Group type: EXPERIMENTAL
Intervention: Brushing twice a day
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Baseline examination
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Year 1 examination
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Year 2 examination
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Year 3 examination
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Restorations at baseline
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Restorations at Year 1
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Restorations at Year 2
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Restorations at Year 3
Number of subjects: 4294
Study: 2697708

Group type: EXPERIMENTAL
Intervention: Pyrimethamine, sulphadiazine and corticosteroids (n = 29)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Clindamycin, sulphadiazine and corticosteroids (n = 37)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (trimethoprim and sulphamethoxazole) and corticosteroids (n = 8)
Number of subjects: 106

Group type: COMPARATOR
Intervention: No systemic therapy (group 4, n = 32)
Number of subjects: 106
Study: 180196

Group type: EXPERIMENTAL
Intervention: Topical treatment with 3% adenine arabinoside
Number of subjects: 63

Group type: COMPARATOR
Intervention: Topical treatment with placebo ointment
Number of subjects: 63

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 63
Study: 31691472

Group type: EXPERIMENTAL
Intervention: MYL-1501D (weeks 0-12), reference insulin glargine (weeks 12-24), MYL-1501D (weeks 24-36)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Reference insulin glargine for 36 weeks
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: MYL-1501D and reference insulin glargine
Number of subjects: 127
Study: 30084719

Group type: EXPERIMENTAL
Intervention: Maternal ADHD treatment (group psychotherapy and open methylphenidate medication)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control treatment (individual counselling without psycho‐ or pharmacotherapy)
Number of subjects: 123
Study: 27576788

Group type: EXPERIMENTAL
Intervention: Workshop
Number of subjects: 69

Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 69
Study: 26256072

Group type: EXPERIMENTAL
Intervention: Internet-delivered handwashing intervention
Number of subjects: 20066

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 20066
Study: 23380864

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 20683602

Group type: EXPERIMENTAL
Intervention: Bipolar coagulation forceps (BiClamp)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 30
Study: 19344605

Group type: EXPERIMENTAL
Intervention: Flexible nasendoscope
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rigid laryngoscope
Number of subjects: 30
Study: 16452248

Group type: EXPERIMENTAL
Intervention: High red meat diet
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High-fiber, high red meat diet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Vegetarian diet
Number of subjects: 21
Study: 14872173

Group type: EXPERIMENTAL
Intervention: F3212 (dengue vaccine containing 3, 2, 1 and 2 log10 of the 50% cell culture infective dose of serotypes 1, 2, 3 and 4)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: F3313 (dengue vaccine containing 3, 3, 1 and 3 log10 of the 50% cell culture infective dose of serotypes 1, 2, 3 and 4)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Purified Vero cell rabies vaccine (control group)
Number of subjects: 103
Study: 11726451

Group type: EXPERIMENTAL
Intervention: 1.0 microg/kg clonidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5 microg/kg clonidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5 microg/kg clonidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 60
Study: 9469535

Group type: EXPERIMENTAL
Intervention: Just painful stimulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mildly painful stimulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moderately painful stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Warm stimulation
Number of subjects: 12
Study: 7910792

Group type: EXPERIMENTAL
Intervention: Higher insufflation pressures
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Lower insufflation pressures
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Chemically inert insufflation gas
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 3294714

Group type: EXPERIMENTAL
Intervention: Emepronium bromide (Cetiprin) 25 mg t.i.d. administered intramuscularly
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo administered intramuscularly
Number of subjects: 60
Study: 29028848

Group type: EXPERIMENTAL
Intervention: Synthetic resorbable membrane (PLA membrane); test group, 30 implants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Collagen resorbable membrane; control group, 30 implants
Number of subjects: 60
Study: 26922496

Group type: EXPERIMENTAL
Intervention: Injection of plasma rich in growth factors (PRGF)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Saline injections (Control)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both groups (PRGF and Control)
Number of subjects: 92
Study: 25697421

Group type: EXPERIMENTAL
Intervention: Generic sevoflurane
Number of subjects: 182

Group type: COMPARATOR
Intervention: Original sevoflurane
Number of subjects: 182
Study: 23715891

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 15 mg/kg body weight intravenously before skin incision
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (0.9% Sodium chloride solution) intravenously before skin incision
Number of subjects: 60
Study: 20832243

Group type: EXPERIMENTAL
Intervention: Topical honey
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lignocaine
Number of subjects: 20
Study: 18594749

Group type: EXPERIMENTAL
Intervention: Thermal water nasal spray 4 times/day for 4 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Saline nasal spray 4 times/day for 4 weeks
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Thermal water nasal spray
Number of subjects: 55

Group type: COMPARATOR
Intervention: Saline nasal spray
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55
Study: 16177612

Group type: EXPERIMENTAL
Intervention: High-level rifle shooters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 12556258

Group type: EXPERIMENTAL
Intervention: Postural drainage and percussion (PD&P)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-frequency chest wall compression (HFCWC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Overall preference among the three methods
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dry sputum weights
Number of subjects: 24
Study: 10720212

Group type: EXPERIMENTAL
Intervention: on-line HFR
Number of subjects: 130

Group type: COMPARATOR
Intervention: hemodiafiltration or modified forms
Number of subjects: 130
Study: 8928167

Group type: EXPERIMENTAL
Intervention: Tacrine
Number of subjects: 0
Study: 1990896

Group type: EXPERIMENTAL
Intervention: Low-dose clonidine (7-cm2 transdermal patch + oral 3 micrograms.kg-1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-dose clonidine (10.5-cm2 transdermal patch + oral 4.5 micrograms.kg-1 at bedtime and 6.0 micrograms.kg-1 on morning of surgery)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (occlusive patch without active ingredient + oral placebo tablets)
Number of subjects: 42
Study: 6129979

Group type: EXPERIMENTAL
Intervention: UK‐33,274 (average dose 4.5 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Prazosin (average dose 2.4 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: UK‐33,274
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 11
Study: 30830844

Group type: EXPERIMENTAL
Intervention: Transinguinal preperitoneal plasty (TIPP)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Lichtenstein repair (LR)
Number of subjects: 205
Study: 28624988

Group type: EXPERIMENTAL
Intervention: Oral mifepristone (400 mg)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Balloon catheter (Foley's catheter 16 Fr; bulb filled with 30 ml normal saline)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Balloon catheter
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 107
Study: 25847374

Group type: EXPERIMENTAL
Intervention: OCT-based mouthwash
Number of subjects: 30

Group type: COMPARATOR
Intervention: Periodontal therapy
Number of subjects: 30
Study: 25127697

Group type: EXPERIMENTAL
Intervention: Diabetic macular edema (DME) patients
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Nonedematous fellow eyes of DME patients
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: DME patients
Number of subjects: 142

Group type: COMPARATOR
Intervention: Healthy control eyes
Number of subjects: 142
Study: 22533725

Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 55

Group type: COMPARATOR
Intervention: Healthy control (normotensive subjects)
Number of subjects: 55
Study: 20095519

Group type: EXPERIMENTAL
Intervention: Telemedicine approach for diagnosis of impacted third molars
Number of subjects: 432

Group type: COMPARATOR
Intervention: Real-time assessment of clinical diagnosis
Number of subjects: 432
Study: 17683402

Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg.kg(-1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 80
Study: 16361558

Group type: EXPERIMENTAL
Intervention: Doxorubicin/paclitaxel followed by CMF (arm B)
Number of subjects: 1355

Group type: COMPARATOR
Intervention: Doxorubicin followed by CMF (arm A)
Number of subjects: 1355

Group type: COMPARATOR
Intervention: Primary systemic therapy (arm C)
Number of subjects: 1355
Study: 15997936

Group type: EXPERIMENTAL
Intervention: EDTA-T gel (5%, 10%, 15%, 20%, 24%) applied for 1, 2, or 3 minutes using passive and active methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active method of EDTA-T application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative control (saline solution)
Number of subjects: 0
Study: 10440417

Group type: EXPERIMENTAL
Intervention: 375 mg loading dose of clopidogrel on day 1, followed by 75 mg daily from day 2 to day 10.
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Loading doses of 75 mg, 150 mg, 225 mg, or 300 mg of clopidogrel on day 1, followed by 75 mg daily from day 2 to day 5.
Number of subjects: 46
Study: 9071055

Group type: EXPERIMENTAL
Intervention: Substance abuse prevention program (two years duration)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Control group (no program)
Number of subjects: 442
Study: 1807657

Group type: EXPERIMENTAL
Intervention: Graphical display of telecommunicated blood glucose data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional diaries
Number of subjects: 0
Study: 6640241

Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg i.v.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Metronidazole 500 mg i.v. + Cefuroxime 1.5 g i.v.
Number of subjects: 70
Study: 31981043

Group type: EXPERIMENTAL
Intervention: Endoscopic Argon Plasma Coagulation (APC)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (multidisciplinary management)
Number of subjects: 42
Study: 30883781

Group type: EXPERIMENTAL
Intervention: Silver fluoride (AgF) treatment
Number of subjects: 210

Group type: COMPARATOR
Intervention: Atraumatic restorative technique (ART)
Number of subjects: 210
Study: 29369731

Group type: EXPERIMENTAL
Intervention: Web-based stress management (STREAM), therapist-guided, duration not specified
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 129
Study: 27179199

Group type: EXPERIMENTAL
Intervention: Village sanitation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 24188914

Group type: EXPERIMENTAL
Intervention: Leg muscle power training using pneumatic variable resistance equipment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low intensity sham exercise
Number of subjects: 0
Study: 22433612

Group type: COMPARATOR
Intervention: URMEL‐ICE intervention focusing on physical activity, TV time, and soft drink consumption, integrated into the curriculum with 29 lessons, 2 exercise blocks per day, and 6 family homework lessons.
Number of subjects: 945
Study: 20733558

Group type: EXPERIMENTAL
Intervention: Trabeculectomy using mitomycin C (MMC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trabeculectomy with ologen implant
Number of subjects: 20
Study: 18052557

Group type: EXPERIMENTAL
Intervention: Vitamin B(6) (daily dose of 1200 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15722001

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) intervention from trained nurses in the community
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) intervention
Number of subjects: 0
Study: 12131685

Group type: EXPERIMENTAL
Intervention: Selective bowel decontamination (SBD) regimen consisting of gentamicin 80 mg + polymyxin E 100 mg + nystatin 2 million units
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nystatin alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Selective bowel decontamination (SBD) regimen
Number of subjects: 80
Study: 10188605

Group type: EXPERIMENTAL
Intervention: C4 level SCI
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: C5 level SCI
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Able-bodied persons
Number of subjects: 3
Study: 7758446

Group type: EXPERIMENTAL
Intervention: 2D visual hierarchy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linear structure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Challenge match interface
Number of subjects: 0
Study: 30616014

Group type: EXPERIMENTAL
Intervention: 5-day course of oral antibiotics (colistin sulphate 2 × 106 IU 4×/day; neomycin sulphate 500 mg 4×/day) followed by frozen faecal microbiota transplantation (FMT) from unrelated healthy donors
Number of subjects: 39

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 39
Study: 30513812

Group type: EXPERIMENTAL
Intervention: Vitamin D tablets (1000 IU/day)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Vitamin D-fortified milk (40 IU/200 mL)
Number of subjects: 125
Study: 26324859

Group type: EXPERIMENTAL
Intervention: Weight loss intervention for the prevention of type 2 diabetes
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Combined mediation model
Number of subjects: 535
Study: 24903663

Group type: EXPERIMENTAL
Intervention: Maternal RSV antibody titers in the third trimester and at birth
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Higher cord blood RSV antibody titers
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Maternal antibody half-life
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Ratio of infant cord blood to maternal serum RSV antibody titers
Number of subjects: 149
Study: 22822092

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (40,000 IU orally per week for 8 weeks)
Number of subjects: 52